FDA Approves of VIZZ Eye Drops to Treat Presbyopia
Summary by Medscape
3 Articles
3 Articles
FDA-approved eye drop 'paradigm shift' for presbyopia patients
The VIZZ eye drop contracts the iris sphincter muscle resulting in a pinhole effect and uniquely achieves a sub-2mm pupil that extends depth of focus. Image: dragonstock/stock.adobe.com.A new, “first-of-its kind” presbyopia drop will soon be available in the US after the Food and Drug Administration (FDA) approved Lenz Therapeutics’ VIZZ (aceclidine ophthalmic solution) 1.44%. A media release said it was expected to be broadly available in the f…


FDA Approves of VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
·United States
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium